You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (17)

Journals (0)

1-10 of 17 results for trastuzumab biosimilar

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Evaluation of cost and infusion-related reactions among intravenous trastuzumab,subcutaneous trastuzumab,and trastuzumab biosimilars at an academic medical center

Retricted access

Research article

First published 2025-4

Evaluation of cost and infusion-related reactions among intravenous trastuzumab,subcutaneous trastuzumab,and trastuzumab biosimilars at an academic medical center

Daijah M Davis, Kasey Jackson, Christina Hoppe

Journal of Oncology Pharmacy Practice

Select article: Physicochemical stability study of MYL-1401O,a biosimilar of trastuzumab,following a transient temperature excursion

Retricted access

Research article

First published 2021-6

Physicochemical stability study of MYL-1401O,a biosimilar of trastuzumab,following a transient temperature excursion

Guillaume Le Guyader, Victoire Vieillard, Muriel Paul

Journal of Oncology Pharmacy Practice

Select article: Clinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US

Open access

Research article

First published 2021

Clinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US

Ran Jin, Reshma L. Mahtani, Neil Accortt [...]

Therapeutic Advances in Medical Oncology

Select article: Physicochemical stability of PF-05280014 (trastuzumab-qyyp;Trazimera TM ),a trastuzumab biosimilar,under extended in-use conditions

Retricted access

Research article

First published 2023-4

Physicochemical stability of PF-05280014 (trastuzumab-qyyp;Trazimera TM ),a trastuzumab biosimilar,under extended in-use conditions

Sarah Weiser, Christopher Burns, Edward R. Zartler

Journal of Oncology Pharmacy Practice

Select article: First-Line Treatment of HER2-Positive Metastatic Breast Cancer With Dual Blockade Including Biosimilar Trastuzumab (SB3): Population-Based Real-World Data From the DBCG

Open access

Research article

First published 2022

First-Line Treatment of HER2-Positive Metastatic Breast Cancer With Dual Blockade Including Biosimilar Trastuzumab (SB3): Population-Based Real-World Data From the DBCG

Alan Celik, Tobias Berg, Lise Birk Nielsen [...]

Breast Cancer: Basic and Clinical Research

Select article: Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital

Retricted access

Research article

First published 2021-8

Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital

Diogo Mendes, Joana Abrantes, Graça Rigueiro [...]

Journal of Oncology Pharmacy Practice

Select article: A Clinical Review of Biosimilars Approved in Oncology

Retricted access

Review article

First published 2021-3

A Clinical Review of Biosimilars Approved in Oncology

Dat Ngo, Jason Chen

Annals of Pharmacotherapy

Select article: Impact of discordant preferred drug status between hospitals and payers for chemotherapeutic biosimilars

Retricted access

Research article

First published 2025-10

Impact of discordant preferred drug status between hospitals and payers for chemotherapeutic biosimilars

Isha Rana, Zhili Fu, Erika N Brown [...]

Journal of Oncology Pharmacy Practice

Select article: Progress in oncology biosimilars till 2020: Scrutinizing comparative studies of biosimilar monoclonal antibodies

Retricted access

Review article

First published 2021-7

Progress in oncology biosimilars till 2020: Scrutinizing comparative studies of biosimilar monoclonal antibodies

Aqsa Safdar, Muhammad Hammad Butt, Abrar Ahmad [...]

Journal of Oncology Pharmacy Practice

Select article: Biosimilars for breast cancer: a review of HER2-targeted antibodies in the United States

Open access

Review article

First published 2019

Biosimilars for breast cancer: a review of HER2-targeted antibodies in the United States

Emily M. Miller, Lee S. Schwartzberg

Therapeutic Advances in Medical Oncology

1
2
10 / page

Article type

Publication date

Subjects

Access